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ABSTRACT
OSTEOGENIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM
CELLS ON THIN FILM TYROSINE DERIVED POLYCARBONATES
by
Tamunotonye Briggs
Mesenchymal stem cells, harvested from adult bone marrow, are promising in the field of
regenerative medicine because of the vast differentiation potential into various cell lines
such as: osteoblasts, chondrocytes, adipocytes, and neurons. Osteogenic differentiation of
human mesenchymal stem cells (hMSC) could be an important tool in the treatment of
orthopedic deficiencies such as bone defects. The extent of in vitro human mesenchymal
stem cell growth, adhesion, motility and differentiation into osteoblasts is a function of
the material surface chemistry which is mediated by protein adsorption onto the surface.
A library of tyrosine derived polycarbonates allows the tailoring of material properties to
suit specific cell response by varying the structure of the polymer at the pendent chain
and the incorporation of PEG in the backbone. Increasing pendent chain length increases
the hydrophobicity of the surface which is hypothesized to support osteogenic
differentiation at a greater extent than hydrophilic surfaces. To determine the extent of
osteogenic differentiation on thin films, cell morphology, cell proliferation, biochemical
assays specific for osteoblasts, cytoskeletal arrangement and cell motility were assessed.
The results of this study show that increasing the pendent chain length does not cause
statistically significant changes in osteogenic differentiation, however the incorporation
of polyethylene glycol in the polycarbonate backbone had a profound affect on cell
morphology, proliferation and mineralization.
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CHAPTER 1
BACKGROUND
1.1 Bone Defects
It is estimated that over 500,000 bone grafts are implanted into diseased and damaged
bone a year [2]. This is due to metabolic disease such as diabetes, traumatic injury and
bone cancers. The traditional approach to bone graft surgery is to use autografts,
allografts or biomaterials. Autografts, bone which is harvested from the patient's body,
usually the hip, is preferred in many cases because the lack of an immune response.
However, there is morbidity associated at the site of harvest due to infection or pain.
Allograft, acellular tissue harvested from a cadaver solves the issue of donor scarcity, yet
the risk of disease transmission as well as the lack of bone in-growth, limits the
widespread use of this product. Biomaterials, such as metals and ceramics have a long
history in orthopedic applications. Both metals and ceramics have been shown to be
bioinert in most cases, meaning that the extent of biological reactions to these materials is
limited. Titanium alloys were chosen in the design of orthopedic implants because of
their high mechanical properties such as high modulus and load bearing properties.
However, high load bearing implants impose a stress shielding effect on adjacent bone
and tissue which prevents proper healing of the defect. This can cause loosening of the
implant and subsequent invasive surgeries.
Tissue engineering is a field that integrates biological scaffolds such as the
extracellular matrix or synthetic biopolymer scaffolds with cells and/or growth factors,
for the purpose of restoring the function of a non-viable or damaged tissue or organ.
1
2Biological or synthetic scaffolds can provide spatial, chemical and mechanical cues that
guide or aid in the differentiation of cells in the area of defect. The tissue engineered
approach to bone graft substitutes is engineering a bone graft substitute that would
support bone ingrowth, be mechanically compatible to the host bone, and be
bioresorbable [27]. Metals are difficult to process into a porous scaffold. However,
ceramics and polymers could be processed into scaffolds. Bruder et al. reported that
human mesenchymal stem cells (hMSCs) on a fibronectin coated porous hollow cylinders
of 60% hydroxyapatite/40% tricalcium phosphate (HA/TCP) implanted in the femoral
gaps of Harlan Nude rats had higher bone integration, strength and stiffness values
compared to cell free implants at 12 weeks [13]. However, ceramics are not ideal in
treating bone defects because of their brittle mechanical behavior and lack of
bioresorbability. Bioresorbable polymer scaffolds would be the ideal substrates to induce
bone ingrowth while providing mechanical support through the degradation process.
The goal of regenerative biology is to restore the function of damaged tissue and
organs. The transplantation of whole viable organs and tissue is an example of
regenerative medicine, however, the shortage of viable organs in the various banks to
accommodate the vast majority of those suffering from diseases and afflictions is a major
concern. Therefore, the focus of regenerative medicine has been placed on stem cell
therapy [42]. The goal of allogenic or autologous stem cell transplantation is to either
repopulate cellular defects or secrete products such as extracellular matrix at the site of
damage such as segmental bone defects.
3Stem cells represent a vast population of undifferentiated cells that have the
ability to differentiate into more specialized cells under defined or random conditions as
well as have the ability to self-renew when undergoing cell divisions. There are a variety
of stem cells that differ in their differentiation potential as well as site of harvest. The
most common stem cells are: embryonic stem cells, hematopoietic stem cells, and
mesenchymal stem cells.
1.2 Embryonic Stem Cells
The most controversial of all stem cells are embryonic stem cells. Embryonic stem cells
have been at the forefront of the political debate in scientific research in this country
since August 9 th 2001, when limitations were placed on the funding of federal research to
a limited number of stem cell lines. Embryonic stem cells are harvested from the inner
cell mass of 5-day old blastocysts. These blastocysts are obtained from the unwanted
leftovers from fertilization treatments from in vitro fertilization banks. Currently, there
are 155 embryonic stem cell lines in the world. Of these only 78 cell lines had been
approved for federal research in the United States. In order to use these cell lines for
human applications, they must be devoid of animal-derived proteins, this reduces the
amount of cell lines to 22, for possible allogenic transplantation.
Embryonic stem cells are pluripotent, in that they can differentiate into cells that
form the three germ layers: ectoderm, mesoderm and endoderm [35]. Embryonic stem
cells have the potential for differentiating into liver, skeletal muscle, endothelial cells,
chondrocytes, cardiomyocytes, hematopoietic cells, neurons, pancreatic endocrine cells
and adipocytes. Despite the vast potential of these stem cells in research and possibly in
4the treatment of diseases, there are many concerns that have limited the use of embryonic
stem cells in tissue engineering applications. One of the concerns is the formation of
teratomas, a specific tumor which contains well-differentiated cells from the three
different germ layers at the site of implantation. Another concern of utilizing embryonic
stem cells is its immunoreactivity. Embryonic stem cells express the cell surface marker:
MHC Class I, which can be recognized by the host T cells and elicit an immune response.
In order to limit the risk of an immune response, a match between the host MHC Class I
and the donor embryonic cells must be made prior to implantation. This may pose a
limitation in the clinical setting, unless an embryonic stem cell bank is created containing
all the possible MHC Class I moieties. The current state of the public policy which limits
the funding of federal research on embryonic stem cells to only 22 cell lines, would limit
this endeavor. Public policy aside, the ethical debate on utilizing embryonic stem cells for
research does not seem to be heading in a definitive direction.
1.3 Hematopoietic Stem Cells
There are two major classes of stem cells derived from adult tissue: hematopoietic stem
cells and mesenchymal stem cells. Hematopoietic stem cells (HSCs) reside in adult bone
marrow close to the endosteum. Under either stochastic or deterministic conditions,
hematopoietic stem cells differentiate into the various blood cells such as neutrophils,
monocytes/macrophages, basophils, eosinophils, erythrocytes, platelets, mast cells,
dendritic cells, B and T lymphocytes[9]. The process of hematopoiesis is tightly regulated
and when disrupted can lead to severe pathologies such as lymphoma, chronic or acute
leukemia. The differential potential of the hematopoietic stem cells is dependent on its
5niche, which is within the bone marrow [38]. The hematopoietic stem cell niche is
supported by other cells such as mesenchymal stem cells, stromal cells and osteoblasts.
Hematopoietic stem cell transplantation is the oldest and well-characterized
example of stem cell transplantation, being practiced in medicine for over fifty years.
This procedure is done to treat those afflicted by blood disorders such as lymphoma and
leukemia. However, in order to assure successful cell engraftment, the host cell and donor
cells must have an immunogenic match through the expression of histocompatibility
locus antigen (HLA). The mismatch will lead to graft versus host disease(GVHD), a
reaction that has severe complications and may compromise the healing process of the
transplant. The in vitro manipulation of HSCs for tissue engineering purposes is not very
successful because HSCs do not expand under in vitro conditions and are non-adherent.
The plasticity of HSCs is limited to blood and immune cells, however, there have been a
few successful attempts of differentiating HSCs to other cell types, such as
hepatocytes[3]. Therefore, for the applications of tissue engineering, HSCs are not
preferred.
1.4 Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are multipotent cells harvested from adult bone marrow.
MSCs have a low frequency in the bone marrow, representing only 1 out of 100,000
nucleated cells. MSCs are promising in regenerative medicine because of the vast
differentiation potential into cells comprising connective tissue. Ethically, mesenchymal
stem cells preferred in research because they are harvested from adults rather than the
embryonic blastocyst, which is the source of debate with embryonic stem cell research.
6These cells are also preferred in research because of the ease of in vitro maintenance and
expansion.
The differentiation potential of mesenchymal stem cells is dependent on its niche,
within the stromal compartment of the bone marrow, or in the case of in vitro culture, the
local microenvironment. Mesenchymal stem cells can differentiate into osteoblasts,
chondrocytes, adipocytes, as well as the stromal cells of the bone marrow which, provide
support to the hematopoietic stem cells.
The isolation and culture of human mesenchymal has been well characterized.
Bone marrow aspirate is taken from the superior iliac crest of the pelvis and fractionated
using a density gradient solution such as Percoll [22]. A low percentage of cells attach in
the initial days of culture. Yet, 12-16 days is sufficient for reaching confluence of MSCs
and depletion of non-adherent hematopoietic stem cells. Cells are cultured using
Dulbecco's Modified Eagle Medium containing 10% Fetal Calf Serum. Human
mesenchymal stem cells are characterized by cell surface markers: CD45-, CD105+,
CD44+, CD29+, and CD31- [8]. These cell surface markers differ from those expressed
on hematopoietic stem cells as well as endothelial stem cells. Mesenchymal stem cells
have been isolated from sites besides bone marrow, such as the periosteum, trabecular
bone, adipose tissue, synovium, skeletal muscle and teeth[14]. The differentiation
potential of mesenchymal stem cells is similar when isolated from different sites.
The clinical implications of mesenchymal stem cells in tissue engineering are
more promising compared to embryonic stem cells. Embryonic stem cells have the
capacity of forming teratomas in vivo, which is not observed with mesenchymal stem cell
transplantation. The immune properties of MSCs are impressive in that there is a
7decreased immune response of the host to donor MSCs because they do not express MHC
Class II, which is expressed on embryonic stem cells [33]. This eliminates the need to
match donor MSCs to host MSCs, thereby eliminating the onset of GVHD.
The in vitro differentiation of human mesenchymal stem cells to specific cell lines
is dependent on the supplementation of components in the culture medium as well as
other manipulations such as genetic engineering. MSC differentiation into specific cell
line leads to a change in cell morphology and a change in function. Chondrogenic
differentiation is best achieved in a three-dimensional culture condition. The in vitro
conditions requires: serum free medium and transforming growth factor-β (TGF-β). In
chondrogenic differentiation pathway, the MSCs express and release extracellular matrix
components such as glycosaminoglycans. Adipogenic differentiation is achieved through
the addition of isobutymethylxanthine in the culture medium. The morphology of MSCs
following adipogenic differentiation is characterized by the inclusion of large lipid
vacuoles[31]. The neurogenic differentiation of MSCs is followed by the addition of
isobutyl methylxanthine and dibutylryl cyclic AMP as well as brain derived neurotrophic
factor and EGF.
The potential therapeutic value of MSC transplantation is promising in areas such
as leukemia treatment, lung fibrosis, and muscular dystrophy. However, the therapeutic
implications of mesenchymal stem cells transplantation have already been most
promising in orthopedic applications. This is due to the ease of cellular engraftment into
skeletal tissue defects. Mesenchymal stem cells have been transplanted to repair spine
fusion, segmental bone and craniofacial defects and articular cartilage and tendon.
81.4.1 Osteogenic Differentiation of Mesenchymal Stem Cells
The potential orthopedic applications of MSC transplantation highlight the need to
implement in vitro osteogenic differentiation protocols that provide a reliable, consistent
culture system that will inevitably be translated into a clinical setting. Osteogenic
differentiation of MSCs has been optimized under many different culture conditions. In
vitro osteogenic differentiation can be achieved through chemical cues from defined
medium, substrate cues from extracellular matrix, genetic cues and mechanical cues[23].
The presence of animal or human recombinant proteins in culture medium is a concern in
osteogenic differentiation of MSCs that may be used in in vivo transplantation. However,
the growth of MSCs is best achieved in cultures containing 10% Fetal Calf Serum and
comparable serum free substitutes have not been as successful in promoting MSC
proliferation. Recombinant bone morphogenic protein, (BMP) which is a member of the
transforming growth factor (TGF-β) has been shown to induce osteogenic differentiation
in vitro. Although the use of recombinant proteins such as BMP has been successful in
MSC differentiation into osteoblasts, it is not preferred because of the delicate nature of
proteins, which may denature over time, among other problems encountered with protein
modification such as glycosylation. Thus, recombinant protein supplementation is not
preferred in long-term cultures. Moreover, the various sources of recombinant proteins
may elicit different responses from cells. This poses a problem if there is an attempt to
synchronize cultures. Therefore, non-protein supplementation to serum based medium is
preferred. Supplements that support osteogenic differentiation are: prostaglandins E2,
Vitamin D3, L-ascorbic acid, dexamethasone and β-glycerophosphate. However, the
most effective combination in inducing osteogenic differentiation is L-ascorbic acid,
9dexamethasone which is a glucocorticoid, and β-glycerophosphate. Vitamin D3 is a
potent supplement to induce mineralization.
When added to control culture medium, these supplements elicit a specific
osteogenic differentiation pathway which can be determined by observing the
morphology and quantifying osteoblast biomarkers. The morphology of an osteoblast is
cuboidal[12], in contrast to the fibroblast-like morphology of a mesenchymal stem cell.
The change in morphology can be observed as early as two days post-osteogenic
induction, however, it is more apparent four days post-osteogenic induction. Osteoblasts
are characterized by the function of secreting proteins such as collagen, and mineral such
as calcium into the extracellular matrix. Osteoblasts are measured for specific biomarkers
such as alkaline phosphatase, an enzyme that is important in bone mineralization, calcium
and osteocalcin, the most abundant non-collagenous protein in bone. In vitro, the
presence of osteocalcin is attributed to the addition of Vitamin D3 in the culture
medium[25].
Mesenchymal stem cells are rather unique from other stem cells in that they have
an affinity to adhere onto tissue culture substrates. Unlike, hematopoeitic stem cells
which are non-adherent, mesenchymal stem cell growth, attachment and differentiation
are a function of the substrate. This property can be manipulated to enhance optimum cell
response in vitro. In vivo, this property is preserved through MSCs interaction with the
extracellular matrix. The extracellular matrix of cartilage is comprised of proteins such as
collagen, elastin and glycosaminoglycans. The extracellular matrix of bone is unique in
that it is comprised of a protein and mineral component. The majority of the protein
component of the bone's extracellular matrix is type I collagen. Other proteins present are
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fibronectin, osteocalcin, osteopontin, bone sialoprotein[7] . The mineral component of the 
extracellular matrix is hydroxyapatite, which is a calcium phosphate. 
MSCs interact with the extracellular matrix proteins via transmembrane receptors 
called integrins. lntegrins are incorporated with the cytoskeletal filaments within the cell 
such as actin, talin and paxillin which forms focal adhesion contacts with the extracellular 
matrix proteins[4]. Signal transduction occurs following integrin-extracellular mauix 
protein binding, by way of adhesion, differentiation and motility. By manipulating the 
composition of the ECM proteins in. vitro and in. vivo, the differentiation of MSCs along a 
specific pathway can occur[28]. Osteogenic differentiation can occur on extracellular 
matrix compositions containing fibronectin, vi tronectin and type I co llagen[36]. 
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Figure 1.1 Interaction between integrin and fibronectin and its relationship to 
cytoskeletal organization. 
1.5 Biomaterials 
The implantation of natural or synthetic materials goes as far back to 4000 years when 
the ancient Egyptians used linen and animal sinew to close wounds. Biomaterials 
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encompass the range of materials that can be implanted into the body, including: metals,
ceramics and natural or synthetic polymers or a composite of these materials. Prior to the
advances in materials science in the last 50 years, biomaterials were derived from natural
sources such as wood, silk and animal connective tissue. In the last 50 years, true
innovations in biomaterials began to be realized. Some important milestones were:
Harold Ridley used poly(methyl methacrylate) for the first intraocular lens, Vorhes
invented the vascular graft, Hufnagel invented the ball and cage heart valve and Chamley
invented the hip implant[32].
1.6 Polymers
Synthetic polymers are high molecular weight materials consisting of many repeat units,
called monomers which are linked together via chemical reaction. Polymers are
characterized by a distribution of molecular weight averages. This is due to the uneven
distribution of chains of monomer units. The structure of the polymer, whether it is a
random coil or semi-crystalline structure plays a critical role in the thermodynamic
properties of the polymer such as the glass transition temperature (T g). This is one factor
that influences the processibility of the polymer. The extent of which polymers can be
fabricated and processed is much greater than metals and ceramics. The ease in
processing polymers into a desired shape and texture makes it an ideal candidate for
creating complex structures such as scaffolds that can have features at the micro and nano
scale.
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Two dimensional in vitro cultures are instrumental for the screening of polymers
intended for two-dimensional scaffold culture. For two-dimensional in vitro cultures,
polymers are fabricated into thin films through solvent casting, spin coating, compression
molding and a number of other techniques. Both solvent casting and spin coating rely on
polymers in solution. The residual solvent that may exist on the surface and can cause a
cytotoxic effect, this can be detected with thermogravimetric analysis (TGA).
Compression molding, on the other hand, is a film fabrication technique where films are
made through the application of heat and pressure through a mold. The temperature
applied to the film is dependent on the polymer's T g . These fabrication techniques may
cause films to have differences in surface topography, which may aid or hinder cell
adhesion as well as differences in mechanical modulus which may affect cell
differentiation.
Understanding the interface between the cells and biomaterials is integral in the
successful implantation of biomaterials. The interface between the biomaterial and the
cell in vitro and in vivo is mediated by protein adsorption. In fact, cells do not interact
directly with the polymer. Therefore, cell behavior is a response to the adsorbed protein.
Protein adsorption is the process in which proteins rapidly adsorbs onto the surface of an
implanted material. In in vitro cultures, serum proteins in the medium in the form of
albumin as well as other proteins adsorb onto the biomaterial surface[1]. Protein
adsorption is influenced by the surface charge or surface wettability of the polymer[40].
Surface wettability is a measure of the affinity towards water. Surface wettability can be
determined by contact angle measurements, which is the angle formed by a liquid on a
solid surface at the three phase boundary. Surfaces which favor water are hydrophilic and
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surfaces that do not favor water are hydrophobic. It has been shown that hydrophobic
surfaces greater influences protein and cell attachment.
Another attractive property of some polymers in tissue engineering applications is
the ability to degrade under physiologic conditions, which is a property of bioresorbable
polymers. Bioresorption occurs in two steps the first step being the process of cleaving a
bond through hydrolysis or an enzymatic reaction to break down a polymer into its
monomer units. At this point, the molecular weight of the polymer decreases which is
followed by the loss of mechanical strength and mass loss. In the second step, the broken
pieces of the implant are attacked by macrophages, which are cells of the immune system
that engulf or phagocytosized foreign particles[30]. This is the beginning of a foreign
body response which ultimately leads to a collagenous capsulation. The extent of this
response can impede the function of an implant.
Over the last forty years, there has been considerable research on bioresorbable
polymers. Bioresorbable polymers are useful in other applications such as drug delivery
vehicles. The most well characterized bioresorbable polymers are classified as poly(a-
esters): poly (glycolic acid) (PGA), poly(L-lactic acid) (PLLA), and its copolymer: poly
(DL-lactic co-glycolic acid) (PLGA)[41]. These particular bioresorbable polymers are
favored for orthopedic applications because of their strong mechanical properties. The
polymerization of PGA is initiated by the ring opening of glycolide, which results in a
linear polyester molecule. PGA has a high degree of crystallinity which contributes to its
very high modulus. The degradation product of PGA is glycolic acid. The polymerization
of PLLA is initiated by the ring opening of lactide, a six membered ring. The L-isomer of
lactide, which is abundantly found in nature, contributes to the semi-crystalline structure
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and which results in a reasonably high tensile strength and high modulus which is less
than PGA. PLLA is more hydrophobic than PGA due to the presence of the methyl
group. When PLLA is degraded, it releases lactic acid which is then metabolically
excreted. Creating a copolymer is desirable because one can tailor the properties of the
copolymer by altering the composition of the two or more polymers. PLGA, a copolymer
of PGA and PLLA has a structure that is not as crystalline as PGA or PLLA
homopolymer. Moreover, the degradation rate of this copolymer is controlled by altering
the composition ratio of PLLA and PGA. The degradation products of PLLA, PLGA and
PGA which are lactic acid and glycolic acid, are natural products. However the acidic
nature of these byproducts may have a deleterious effect on the surrounding cellular
environment and impede healing[39]. Furthermore, the bulk degradation of these
materials produces crystalline particles which are phagocytosized by macrophages
through the foreign body response, which may lead to a collagenous encapsulation.
These materials have many limited mechanical and thermodynamic properties.
There are other bioresorbable polymers that are utilized in clinical settings: poly(c-
caprolactone), poly(orthoesters), poly(anhydrides) and poly(dioxanone). These polymers
have various mechanical properties and thermodynamic properties, which can be utilized
for a specific application. These polymers have also been copolymerized with other
bioresorbable polymer constituents to tailor a specific property.
1.7 Tyrosine Derived Polycarbonates
The field of bioresorbable polymers has been successful in the development of
commercial medical devices and drug delivery systems for the past thirty years.
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However, new approaches to the design of bioresorbable polymers with alternative
degradation profiles, mechanical properties are being developed. The combinatorial
chemistry approach to designing biodegradable polymers has the potential to offer an
array of materials with a wide range of thermodynamic and mechanical properties. This
approach developed by Dr. Joachim Kohn at Rutgers University was used to design a
library of structural-related tyrosine derived polycarbonates and polyarylates, which are
pseudo poly(amino acids).
In theory, poly(amino acids) would be an ideal candidate for biodegradable
polymers because of the structural similarity with natural amino acids. However,
poly(amino acids) were shown to have poor mechanical properties as well as elicit
immunogenicity. The development of pseudo poly(amino acids) relies on synthesizing
non-peptide linkages such as ester, carbonate and iminocarbonate bonds in the polymer
backbone structure[10]. Tyrosine is a phenolic amino acid which when dimerized is
chemically similar to Bisphenol A, a diphenol that has been used commercially to
enhance the mechanical properties of polymers. Bisphenol A is not favorable in the
context of biodegradable polymers because of its cytotoxicity and its inability to degrade.
It was determined that rather than creating a tyrosine dipeptide, polymerizing a
desaminotyrosine and desaminotyrosyl alkyl ester would provide the appropriate desired
mechanical properties. Tyrosine derived polycarbonates have the same backbone but
differ in the alkyl ester pendent chain. The ester bonds contribute to the degradation
properties of the material. These materials are denoted by the nomenclature
desaminotyrosyl-tyrosine alkyl esters (DTR) carbonate. The length of the pendent chain
is denoted by the nomenclature: desaminotyrosyl-tyrosine ethyl ester (DTE),
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desaminotyrosyl-tyrosine butyl ester (DTB), desaminotyrosyl-tyrosine octyl ester (DTO),
and desaminotyrosyl-tyrosine dodecyl ester (DTD). In the development of tyrosine
derived polyarylates, two parameters can be independently altered: the backbone and the
alkyl ester pendent chain length.
Figure 1.2 Tyrosine Derived Polycarbonate.
The length of the pendent chain influences the extent of most of the mechanical,
thermal and surface wettability properties. This is most evident in the wide range of glass
transition temperatures (Tg)of polycarbonates which range from (52°C-93°C) [18],
decreasing with the addition of each methyl group in the alkyl ester chain. The T g 's for
these amorphous materials are high enough to use under physiological conditions, where
the average temperature is 37°C, and high enough to ensure reasonable thermal
processing techniques. The molecular weight is also a function of the pendent chain
length. The weight-average (Mw) molecular weight of polycarbonates is between 176-
450 kDa. The surface wettability decreases with the addition of methyl groups in the
pendent chain, becoming more hydrophobic. The mechanical properties of these
materials, measured in mechanical strength and stiffness is relatively high, making these
materials ideal candidates in orthopedic applications. The rate of the degradation, which
under physiologic conditions proceeds through the hydrolysis of the ester bond and the
carbonate bond increases with the length of the pendent chain. The by-products of the
degradation are desaminotyrosine and L-tyrosine, an amino acid which does not elicit a
cytotoxic effect on surrounding cells.
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The in vivo response to the degradation of tyrosine derived polymers compared to
PLLA was evaluated in a study completed by Hooper et al. Extruded pins of poly(DTE
carbonate), poly(DTE adipate) and PLLA were implanted subcutaneously in rats. The
degradation of these materials was evaluated along with water uptake, mass loss and
tissue response over a 570 day span. It was shown that complete resorption of poly(DTE
adipate) was achieved within two years[24]. The resorption of poly(DTE carbonate) is
hypothesized to take more than three years, which is similar to PLLA. The tissue
response, according to the incidence of inflammation, to poly(DTE carbonate) and
poly(DTE adipate) was more favorable than PLLA.
Traditionally, PEGylation, the process of poly(ethylene glycol) (PEG)
incorporation into substances has been used in the pharmaceutical industry to the increase
lipid clearance of highly hydrophobic drugs and proteins[21]. The incorporation of
hydrophobic moieties to PEG can produce a surfactant, a material with a hydrophobic
head and hydrophilic tail. This was an important discovery in drug delivery. PEG is an
ideal material in drug delivery and biomedical implants because of its bioinert and non-
immunogenic properties.
Surface property modification, mechanical strength and degradation rates can be
affected by the incorporation of PEG through copolymerization. The properties of PEG
are dependent on its molecular weight. High molecular weight PEG moieties of PEG act
more as solids in contrast to liquid nature of low molecular weight moieties of PEG. The
development of tyrosine derived polycarbonates provided another library of materials in
which the surface properties and mechanical properties could be tailored to the
application of the material. This is achieved through the manipulation of three
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parameters: the percent mole fraction of PEG in the polymer backbone, average
molecular weight of PEG, and pendent chain length[45]. Copolymerization is carried out
by a condensation reaction of desaminotyrosyl-tyrosine alkyl ester with the desired molar
fraction of PEG in the presence of phosgene. The addition of PEG has a positive
correlation of water uptake and at high enough mole fraction (15%), results in hydrogel
like properties. At lower PEG concentrations (less than 5%), the copolymers possess
comparably strong mechanical properties such as tensile stiffness and strength, which
decreases at PEG concentrations above 5% to produce flexible elastomers. The addition
of PEG into the polycarbonate backbone increases the degradation rate by making it more
susceptible to hydrolytic cleavage because of PEG'S water uptake properties.
Figure 1.3 Tyrosine Derived Polycarbonate PEG copolymer.
Compared to other polymers, PEG does not promote surface protein adsorption
and subsequent cell attachment[17]. Protein adsorption and protein bioactivity and
conformation leads to significant effects in cell adhesion and motility which can be
modified through the addition of PEG in the backbone structure of polycarbonates at
various molar concentrations. In a study completed by Tziampazis et al., where human
fibronectin was adsorbed onto PEG polycarbonates ranging from 0-10% molar fraction,
the amount of fibronectin adsorbed and its bioactivity decreased at PEG molar fractions
greater than 6%[43]. Cell adhesion was also negatively affected at concentrations above
6%. Cell motility is an important parameter to study organogenesis, tissue remodeling,
pathologies and bone remodeling. The incorporation of PEG in the backbone of
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polycarbonates had a pronounced effect on cell motility. It was found that PEG molar
concentration had a biphasic effect on cell speed, the cell speed of L929 cells increased
with increasing PEG molar concentrations up to an intermediate PEG concentration (3-
4%), yet at higher PEG concentrations (>8%), is motility decreased[37].
The in vivo and in vitro response to tyrosine derived polycarbonates has been well
characterized. Polycarbonates have been shown to be biocompatible to a number of cell
lines such as osteoblasts and fibroblasts. Because of its biocompatibility, these
polycarbonates can be used in many biomaterial applications including orthopedics.
Polycarbonates have been used in a number of in vivo orthopedic studies where
mechanical strength, degradation, tissue response, bone apposition was evaluated over
time. In a few studies, polycarbonates were extruded into fracture fixation pins for
implantation into the transcortical femoral defect in rabbits. The polycarbonates,
contained different pendent chain lengths: poly(DTE carbonate), poly(DTB carbonate),
poly(DTH carbonate) and poly(DTO carbonate). In a 3-year study completed by James et
al., histological samples were studied at short term and long term timepoints. It was
shown that these materials were osteocompatible, meaning that there was no bone
resorption and presence of inflammatory cells at the implant site[26]. However, at the
bone-implant interface, bone apposition was shown to be a function of the pendent chain
length, where direct bone apposition was observed at higher frequency on poly(DTE
carbonate) at short term and long term timepoints compared to longer pendent chain
moieties such as poly(DTB carbonate) and poly(DTO carbonate). At the bone implant
interface on poly(DTB carbonate), the presence of fibrous encapsulation was observed at
higher frequency (79%) than bone apposition at short term and long term timepoints. This
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effect was observed with poly(DTO carbonate), where the presence of fibrous
encapsulation is 83%. Whereas, the frequency of fibrous encapsulation of poly(DTE
carbonate) was 27% while the frequency of bone apposition is 73%. This highly suggests
that the stepwise addition of methyl groups has a dramatic affect in vivo.
In the canine bone chamber study completed by James et al., bone ingrowth was
observed. In this study, coupons of compression molded films of poly(DTE carbonate),
poly(DTH carbonate) and PLLA were placed in a chamber into a longitudinal defect in
both the distal femurs of dogs. It was observed that bone ingrowth into poly(DTE
carbonate) and poly(DTH carbonate) was comparable to PLLA[15]. However, the
presence of fibrous encapsulation was observed at higher frequency on PLLA and to a
lesser extent on poly(DTH carbonate), and not observed on poly(DTE carbonate).
The previous mentioned in vivo studies highlight the osteoinductive properties of
tyrosine derived polycarbonates compared to standard biodegradable polymers such as
PLLA. This property, along with bioresorbability and mechanical strength make tyrosine
derived polycarbonates an ideal substrate for allogenic mesenchymal stem cell
transplantation with the potential to differentiate into osteoblasts. Another important
finding in these in vivo studies is the direct correlation of pendent chain length to fibrous
encapsulation, a negative effect of implantation which impedes healing. Although
polycarbonates have been shown to have fewer incidences of fibrous encapsulation
compared to PLLA, the addition of methyl groups in the pendent chain length increases
the onset of fibrous encapsulation.
CHAPTER 2
RESEARCH OBJECTIVE
The development of a library of polycarbonates has lead to polymers with an array of
material properties such as molecular weight, T s, water uptake, and surface wettability.
The goal of this study was to determine the effect of the alkyl ester pendent chain length
or PEG incorporation into the polycarbonate backbone, on the osteogenic differentiation
of human mesenchymal stem cells on thin film substrates. The polymers that were chosen
in this study were: poly(DTE carbonate), poly(DTO carbonate), poly (DTE co 3% PEG-
1K carbonate), poly(DTE co 4% PEG-1K carbonate) and poly(DTE co 5% PEG-1K
carbonate). Poly(DTE carbonate) and poly(DTO carbonate) differ in the length of the
alkyl ester pendent chain. The PEG copolymers have various molar percentages
incorporated in the polycarbonate backbone. Two thin film preparation techniques:
solvent casting and spin coating will be compared to determine their effect on osteogenic
differentiation.
In this study, it was postulated that polycarbonates of lower surface wettability or
higher hydrophobicity will induce adsorption of a relatively thick layer(s) of proteins that
will serve as ligands for the integrin binding domains on the cell, which will lead to
signal transduction by way of adhesion, osteogenic differentiation and motility in the
presence of osteoinductive (OS) medium. In contrast, polycarbonates containing PEG,
will have comparably higher surface wettability or higher hydrophilicity. This will induce
a relatively thinner, heterogenous layer of proteins, limiting the ligand-integrin binding
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and therefore, altering signal transduction by way of adhesion, osteogenic differentiation
and motility. In a previous study conducted by Godbole et al. 191, hMSCs seeded on
polyarylates of varying degrees of surface wettability had greater osteogenic
differentiation on the more hydrophobic surfaces. Therefore, in this study it is
hypothesized that the addition of methyl groups in the pendent chain, from ethyl to octyl,
which results in an increase in the hydrophobicity, will have an increased effect on
osteogenic differentiation. In contrast, the incorporation of PEG into the polycarbonate
backbone will have a decreased effect on osteogenic differentiation due to the
hydrophilicity.
In vitro osteogenic differentiation will be evaluated with standard quantitative
biochemical marker assays, qualitative morphology and cytoskeletal observations,
quantitative protein adsorption measurements and cell motility measurements.
CHAPTER 3
EXPERIMENTAL METHODS:
3.1 Polymer Processing
Poly(DTE carbonate), poly(DTO carbonate), poly(DTE co 3% PEG-1K carbonate),
poly(DTE co 4% PEG-1K carbonate) and poly(DTE co 5% PEG-1K carbonate) were
obtained from the laboratory of Dr. Joachim Kohn at Rutgers University. It was
important to maintain consistency so lot numbers were maintained throughout the study
as much as possible. The molecular weights were obtained from gel permeation
chromatography (GPC).
Thin film substrates were fabricated using two different methods: solvent casting
and spin coating. Solvent cast films were used in a 96 well plate format while spin coated
films were used in a 24 well plate format.
3.1.1 Solvent Casting
A 1% (w/v) polymer solution was made in methylene chloride and filtered with a 0.45
inn PTFE filter (Whatman). 300 !IL of polymer solution was pipetted into each well of a
96 well polypropylene plate. The plates were placed in a chemical hood overnight for
polymer solvent evaporation.
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3.1.2 Spin Coating
Spin coated disks were prepared following a protocol developed by Brocchini[11]. Glass
cover slips (15 mm) were subjected to a cleaning and poly(styrene silane) coating prior to
spin coating. Glass coverslips were sonicated twice in 25% NaOH for ten minutes and
then twice in 25% HCl for ten minutes. The glass cover slips were sonicated in 2% Micro
detergent for 30 minutes twice and then rinsed with deionised water following each
sonication step. The glass cover slips were then sonicated twice in ethanol for 5 minutes
and methylene chloride twice for 5 minutes. The cover slips were then twice rinsed in
ethyl acetate and then sonicated in a 2.5% (w/v) poly(styrene-silane) copolymer-ethyl
acetate solution and then soaked for an additional 10 minutes. The cover slips were then
placed in a 60°C vacuum oven for 48 hours to anneal the poly(styrene-silane) onto the
surface. Cover slips were removed from vacuum oven and cooled to room temperature
then rinsed twice with ethyl acetate, methanol and ethyl acetate. The cover slips were left
to air dry on aluminum prior to spin coating. A 2.5% (w/v) polymer solution in
methylene chloride was made and filtered with a 0.45 μm PTFE syringe filter
(Whatman). Cover slips were placed in an enclosed chamber of constant humidity (less
than 20%) and temperature, on top of the spin coater (Headway, Garland, TX). Polymer
solution was added to cover slip and the cover slip spun at 2000 rpm for 20 seconds.
Cover slips were placed in tissue culture polystyrene (TCPS) petri dish prior to
experiments. Cover slips were fixed to the bottom of TCPS 24 well plates with methylene
chloride. Plates were degassed for at least 48 hours to ensure methylene chloride
evaporation.
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Air-water contact angle measurements were taken on spin coated disks made of a
1% polymer solution using the methods described by Brocchini. Contact angle
measurements were made on a goniometer (Rame-Hart, Netcong, NJ) using double
distilled waters as the probe. A sessile drop was deposited on the spin coated glass disk of
approximate diameter of 2.5 mm.
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3.2 Cell Culture
In this study, human mesenchymal stem cells (hMSCs) were isolated from commercially
obtained (Cambrex) bone marrow aspirates collected from the superior iliac crest of the
pelvis of male donors (18-36). The isolation method described in detail by Haynesworth,
proceeds with washing the marrow sample with (Phosphate Buffered Solution) PBS then
centrifuging the sample in a 70% density gradient solution at 13,000g for 20 minutes. The
hMSC fraction was collected and then plated into tissue culture polystyrene flasks (Nunc)
with control medium: Dulbecco's Modified Eagle Medium (Invitrogen) containing 10%
Fetal Bovine Serum (Hyclone) and l% Antibiotic-Antimycotic (Invitrogen), then placed
in a 37°C, 5% CO2 containing humidified incubator. On average, confluency of hMSCs
was achieved within 12-16 days. At the point of near confluency, cells were detached
from the substrate with 0.25% Trypsin-EDTA (Invitrogen). Cells were resuspended in
control medium and centrifuged at 900 g for 5 minutes. The cells were then collected and
replated into a new tissue culture flask. This procedure called serial passaging or
subculturing was done up to a maximum of 5 passages. After each passage, cells were
cyropreserved in freezing medium containing 90% Fetal Bovine Serum and 10% DMSO.
The cyropreserved cells were stored in a liquid nitrogen tank until the initiation of an
experiment.
In this study, in vitro osteogenic differentiation was induced by adding
osteoinductive medium (OS medium) which is control medium supplemented with 10
mM beta glycerophosphate (Sigma, St. Louis, MO), 50μM L-ascorbic acid phosphate
(Wako, Richmond, VA) and 100 nM of dexamethasone (Sigma), 24 hours after initial
hMSC seeding.
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3.3 Biochemical Assay Experiment Design
In this study, osteogenic differentiation of hMSCs was determined by observing cell
morphology and quantifying cell proliferation and osteogenic biomarkers such as alkaline
phosphatase, calcium. A baseline of osteogenic differentiation was determined by
comparing undifferentiated hMSCs to differentiated hMSCs.
3.3.1 Cell Morphology
Cell morphology was observed at various points of the 14 day culture. Cells were
observed under bright field, inverted light microscope (Nikon Eclipse TS 100) at 10X,
20X and 40X. Images were taken with a digital camera (Nikon DXM 1200F) and were
visualized with an image analysis software (Metavue, Downingtown, PA).
3.3.2 Cell Proliferation
Cell proliferation was determined with the PicoGreen® ds DNA quantitation kit
(Molecular Probes, Carlsbad, California). The PicoGreen reagent fluorescently labels
double stranded DNA which is correlated to cell number using a standard curve.
Standards of known cell number and samples were prepared by lysing cells with 0.1%
Triton X-100 which were pipetted into each well of a 96 well plate. PicoGreen reagent
was prepared in a 1:200 dilution in buffer solution. 100 lit of the reagent was pippetted
into standards and samples. The fluorescence was detected with FLX800 microplate
reader (Biotek, Winooski, Vermont) at 480 nm excitation/ 520 nm emission.
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3.3.3 Alkaline Phosphatase
The activity of alkaline phosphatase was determined by quantifying the conversion rate
of para-nitrophenyl phosphate (p-Npp) to para-nitrophenol (p-Np) which occurs in the
presence of alkaline phosphatase. Standards of p-Np were prepared in phosphatase
buffer. The samples were prepared by lysing cells with 0.1% Triton X-100, and pipetting
25 [IL of the sample into a 96 well plate with 75 μL phosphatase buffer. The samples and
standards were incubated at 37°C for 30 minutes in a water bath. The reaction was
stopped by adding 0.1 N NaOH into each well. The absorbance was read at 405 nm with
an absorbance plate reader (Molecular Devices). The activity was normalized to cell
number determined from the cell proliferation data, is expressed as nmol of p-
Np/min/cell.
3.3.4 Calcium
The amount of calcium present in the extracellular matrix of the samples was determined
using the Calcium Kit (Thermal Electron). Calcium standards (Sigma) were prepared in
0.5 N HCl. The samples were prepared by hydrolyzing the substrates in a 0.5 N HCl
solution on a vortex overnight. The samples were centrifuged and the supernatant was
collected. A working solution provided by the kit was prepared and added to the samples
and standards. The, presence of calcium was indicated by a strong purple color which was
detected with an absorbance plate reader (Molecular Devices) at 570 nm. Calcium was
also normalized to cell number.
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3.4 96 Well Plate Experiments
Polymers were solvent cast onto 96 well polypropylene plates in methods detailed above.
Cells grown on tissue culture polystyrene (TCPS) served as the internal control for the
experiment (refer to Appendix A). Each polymer had a sample size of 4 wells (n=4).
On the day that the experiment is initiated, day 0, cyropreserved cells were
thawed and counted using Trypan Blue Exclusion dye (Sigma) and a hemacytometer. A
cell suspension in control medium was prepared and 10,000 cells (3.1*10 4 cells/cm2)
were seeded into each well. One day after initial cell seeding, osteogenic differentiation
was induced with OS medium in designated wells.
Throughout the duration of the experiment (14 days), undifferentiated cells were
maintained in control medium and differentiated cells were maintained in OS medium
which were all fed twice a week. On day 12, osteogenic cells were cultured with medium
supplemented with Vitamin D3: 10mM of β-glycerophosphate, 5μM of L-ascorbic acid
phosphate and 10 nM of Vitamin D3, to induce osteocalcin production. The cells were
harvested for biochemical assays at days: 4, 7, 11 and 14. At day 4, cell proliferation and
alkaline phosphatase assays were conducted. On days 7, 11 and 14, cell proliferation,
alkaline phosphatase and calcium assays were conducted.
3.5 24 Well Plate Experiment
Spin coated disks of polymers were fixed onto TCPS plates in methods detailed above.
Cells grown on tissue culture polystyrene (TCPS) served as the internal control for the
experiment (refer to Appendix A). Each polymer had a sample size of 3 wells (n=3).
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On the day that the experiment is initiated, day 0, cyropreserved cells were
thawed and counted using Trypan Blue Exclusion dye and a hemacytometer. Due to the
limited amount of cells available, a cell suspension of 40,000 cells (2.2* l04 cells/cm2)
were seeded into each well rather than (3.1 * 104 cells/cm2). Osteogenic differentiation and
cell culture was similar to 96 well plate experiments. The cells were harvested at
timepoints: days 7, 11 and 14 for cell proliferation, alkaline phosphatase, calcium assays.
3.6 Cytoskeletal Staining
Cytoskeletal organization was observed by fluorescently staining the f-actin filaments
with Alexa Fluor® 488 phalloidin (Molecular Probes, Eugene, OR). Cells were seeded in
the 96 well plate format. Each polymer had a sample size of 2 wells (n=2).
At day 0, cyropreserved cells were thawed and counted. A cell suspension in
control medium was prepared and 10,000 cells (3.1*10 4 cells/cm2) were seeded into each
well. 24 hours after initial cell seeding, osteogenic differentiation was induced with OS
medium in designated wells. Cells were harvested for the staining at timepoints: 1 hours,
5 hours, 24 hours, day 4, day 7, day 11 and day 14. Cells were fixed with formaldehyde
for 20 minutes, rinsed with PBS and fixed with 0.1% Triton X-100 for 5 minutes. The
cells were then rinsed with PBS 2-3 times. The cells were then stained with a 1:100
dilution of the Alexa Fluor 488® phalloidin in PBS for a minimum of 40 minutes. The
cells were then rinsed with PBS 2-3 times and fixed with anti-stain. Fluorescent images
were obtained using the 450 nm-490 nm excitation/505 nm emission filter on the Nikon
fluorescence microscope.
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3.7 QCM-D
The adsorption of fetal bovine serum (FBS) on polymer surfaces was measured in real-
time with a Quartz Crystal Microbalance with Dissipation monitoring (QCM-D)
instrument (Q-sense AB, Goteborg, Sweden). In the Q-CMD, an alternating electric field
is applied to a quartz crystal at resonance frequencies of 5 MHz or at one of its overtones
of: 15 MHz, 25 MHz, 35 MHz and 45 MHz. Protein adsorption or desorption is measured
in the change in frequency (Δf) and dissipation (ΔD) of the quartz crystal due to the
increase or decrease of mass bound to the crystal. The adsorbed mass thickness and
viscosity can be obtained by modeling the Δf and ΔD data using the Voight model
available in the Q-Sense software package.
Sample preparation is described in detail in Weber's paper (2005) [44]. Gold-
coated quartz crystals (5 MHz, Q-Sense, Goteborg, Sweden) were spin coated with a 1%
w/v polymer solution in methylene chloride. The polymers used for this analysis were:
poly(DTE carbonate), poly(DTE co 3% PEG-1K carbonate), poly (DTE co 5% PEG-1K
carbonate) and poly(DTO carbonate). The crystals were then treated in a solution
containing 30% H202, NH4OH and deionized water for 15 minutes at 80°C. The crystals
were then rinsed with deionized water, dried under nitrogen and exposed to UV and
ozone for 10 minutes and rinsed with pure ethanol prior to use.
Protein adsorption experiments occurred at 37°C under a flow rate of 20μL/min.
In one experiment, a 10% solution of FBS (Sigma) in Phosphate Buffered Saline (PBS)
was adsorbed onto the polymer coated quartz disks. Protein-free PBS was added after
surface saturation to determine the irreversibility of protein adsorption. The change in
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frequency (At) and dissipation (AD) was determined at the 9 th overtone of 45 MHz and
plotted for each polymer sample.
3.8 Cell Motility
The motility of hMSCs was observed and measured using confocal microscopy. On day 0
of the experiment, cyropreserved hMSCs were thawed and counted. A concentration of
3000 cells/cm2 was seeded onto spin coated disks of: poly(DTE carbonate), poly(DTE co
3% PEG-1K carbonate), poly(DTE co 4% PEG-1K carbonate) and poly(DTE co 5%
PEG-lK carbonate) which had been mounted inside a glass chamber. Each chamber was
collected at timepoints: 18 hours, days 4, 7, 11 and 14. At day 0, 3 hours after initial cell
seeding, cells were stained with 1 of the fluorescent probe, Cell Tracker (Molecular
Probes, Eugene, OR) in control medium for 30 minutes at 37°C. The Cell Tracker
solution was replaced with CO2 independent medium (Invitrogen) and the chamber was
placed on a 37°C incubated microscope stage on a confocal microscope (Leica). Ten
sample areas which had approximately 200 cells per area, were taken of each film.
Images were taken every 10 minutes for 18 hours. Cells in the remaining chambers were
induced with OS medium, 24 hours after initial cell seeding and placed in a 37° C, 5%
CO2 incubator until the date of harvest. On the date of harvest, the medium in the
chamber was replaced with the Cell Tracker solution for 30 minutes at 37°C. The same
procedure described above was followed with the remaining cell cultures to track cell
motility.
The parameters that defined cell motility in this study were: average velocity,
which is the rate of displacement over increments of time, random motility coefficient,
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and persistence time, which is the length of time a cell travels in a straight line. These
parameters are displacement dependent, where displacement was measured as a function
of time, by tracking the x and y coordinates of the cell centroid, using Image Pro software
(Media Cybernetics, Silver Spring, MD). The calculation of the persistence time and
random motility coefficients as a function of time, was derived from the following
equation: D 2(ti)=4µ(t-P), [29] where D 2(ti) is the squared displacement as a function of
time, pt is the random motility coefficient and P is the persistence time. Average velocity,
S, is obtained from the calculation: D 2 = 2S2P[t-P(1-e(-t/p))]. Matlab was used to compute
calculations.
CHAPTER 4
RESULTS AND DISCUSSION
4.1 Contact Angle Measurements
One characterization method of the surface is the contact angle measurement. Contact
angle measurements are an indication of surface wettability, which in the case of tyrosine
derived polycarbonates is modified by the addition of methyl groups in the alkyl ester
pendent chain. It is observed in Table 4.1, that the average contact angle 10°, when going
from poly(DTE carbonate) to poly(DTO carbonate), an addition of 6 methyl groups.
Likewise, the incorporation of PEG into the polycarbonate structure is lower compared to
poly(DTE carbonate), indicating that these polymers: poly(DTE co 4% PEG-1K
carbonate) and poly(DTE co 5% PEG-1K carbonate) are more hydrophilic than
poly(DTE carbonate).
Table 4.1 Contact Angle Measurements, n=3
St.
Material 	 Contact Angle / ° Dev.
Poly(DTE carbonate) 	 77.7 	 0.6
Poly(DTO carbonate) 	 87.3 	 4.6
Poly(DTE-co-4%PEG K carbonate) 	 71.7 	 2.0
Poly(DTE-co-5%PEG  K carbonate)  	 72.3   2.5
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4.2 Cell Morphology
In this experiment, cell morphology is a visual representation of the cells on the substrate.
Below are bright field images of undifferentiated hMSCs and osteogenic differentiated
hMSCs (OS) cells at various timepoints in a 14 day culture. Experiments for both 96 well
plate and 24 well plate were conducted in October 2005 using hMSC, Donor 2, passage
2. Undifferentiated hMSCs on poly(DTE carbonate), poly(DTO carbonate) (Figure 4.1c
and Figure 4.2c, respectively) are characterized by a fibroblast-like morphology, while
undifferentiated hMSCs on poly(DTE co 5% PEG-1K carbonate) are characterized by
aggregates (Figure 4.3c). Osteogenic differentiated hMSCs (OS) are characterized by a
cuboidal morphology. At high confluence, by day 7, the monolayer has a cobble-stone
like morphology (Figure 4.le and 4.2e). However, cells on poly(DTE co 5% PEG-1K
carbonate) do not produce a monolayer, rather cells on poly(DTE co 5% PEG-1K
carbonate) form aggregates as early as four hours after initial cell seeding (Figure 4.7a).
4.2.1 96 Well Plate Experiment 
Bright-field images of cells on solvent cast films. 
Figure 4.1 Cells on poly(DTE carbonate), lOX: undifferentiated hMSCs at (a) 4 hours, 
(b) day 4, and (c) day 7; OS cells at (d) day 4 and (e) day 7. 
Figure 4.2 Cells on poly(DTO carbonate), lOX: undifferentiated hMSCs at (a) 4 hours, 
(b) day 4, and (c) day 7; OS cells at (d) day 4 and (e) day 7. 
• 
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Figure 4.3 Cells on poly(DTE co 5% PEG-I K carbonate), lOX : undifferentiated hM SCs 
at (a) 4 hours, (b) day 4, (c) day 7; as cells at (d) day 4 and (e) day 7. Arrows indicate 
areas of ce ll aggregation. 
Figure 4.4 Cells on ti ssue culture polystyrene (TCPS), lOX : undifferentiated hMSCs at 
(a) 4 hours. (b) day 4, (c) day 7; as cell s at (d) day 4 and (e) day 7. 
4.2.2 24 Well Plate Experiment 
Bright-field images of cells on spin coated disks. 
Figure 4.5 Cells on poly(DTE carbonate) , lOX: undi ffe rentiated hMSCs at (a) 4 hours, 
(b) day 7 and (c) day II ; OS cell s at (d) day 7 and (e) day II . 
, 
" 
Figure 4.6 Cells on poly(DTO carbonate), lOX: undifferentiated hMSCs at (a) 4 hours, 
(b) day 7 and (c) day II ; OS cells at (d) day 7 and (e) day II . 
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Figure 4.7 Cells on poly(DTE co 5% PEG-I K carbonate), lOX: undifferentiated hMSCs 
at (a) 4 hours, (b) day I and (c) day 3: OS cells at (d) day 4 and (e) day 7. Arrows 
indicate areas of aggregation. 
Figure 4.8 Cells on TCPS, lOX : undifferentiated hMSCs at (a) 4 hours, (b) day 4, and 
(c) day 7; OS cells at (d) day 7 and (e) day II . 
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4.3 Biochemical Assays: 96 Well Plate Experiment
The following section is the quantitative representation of osteogenic differentiation in
terms of cell proliferation, alkaline phosphatase activity and calcium production on
solvent cast films in 96 well plates. Below are the results of an experiment conducted in
July 2005, using hMSCs, Donor 2, passage 2. For each experiment, two graphs are
represented: one representing undifferentiated hMSCs and osteogenic differentiated
hMSCs (OS) (Figures 4.9, 4.11 and 4.13), and the other representing only osteogenic
differentiated hMSCs (OS cells) (Figures 4.10, 4.12, 4.14 and 4.15). Data analysis was
conducted using the Tukey-Kramer test between the OS cells on the polymer substrates.
4.3.1 Cell Proliferation
In this experiment cell proliferation over a 14 day culture was quantified using the DNA
assay (Figure 4.9 and 4.10). For the duration of the experiment, the number of cells was
much lower on poly(DTE co 5% PEG-1K carbonate) compared to the other materials. On
poly(DTE carbonate) and poly(DTO carbonate) substrates, cell number reached a
maximum at either days 7 and 11. At day 14, cell number sharply decreases on all
polymers except for OS cells on poly(DTE carbonate). This effect could be attributed to
contact inhibition of the substrate.
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Figure 4.9 Cell proliferation of undifferentiated hMSCs (control) and as cells on 
polymer substrates. Asterisks indicate statistical difference. (p<0.05) between as cells on 
poly(DTE co 5% PEG- l K carbonate) and as cells on both poly(DTE carbonate) and 
poly(DTO carbonate). 
42 
Cell Proliferation 
20000 
--- poly(DTE co 
... 18000 
5% PEG CI) 
.0 16000 T carbonate )-E 
:l 14000 OS z 12000 poly(DTE 
CI) 10000 carbonate )-() 
CI) 8000 OS 01 
* <a 6000 ... 
CI) 
4000 --...- poly(DTO > 
c:( 
2000 carbonate )-
0 OS 
Cell # at Day4 Day? Day 11 Day14 
dayO 
Date of Harvest 
Figure 4.10 Cell proliferation of OS cells on polymer substrates. Asterisks indicates a 
statistica lly significant difference (p<0.05), between poly(DTE co 5% PEG-I K 
carbonate) to both poly(DTE carbonate) and poly(DTO carbonate). 
4.3.2 Alkaline Phosphatase 
Alkaline Phosphatase activity is a marker for osteogenic differentiation. Alka line 
Phosphatase activity was negligible in undifferentiated hMSCs. Alkaline Phosphatase 
activity of OS cells wasn't apparent until after day II (Figure 4. 11 and Figure 4. 12). 
Alkaline Phosphatase activity in OS cells on poly(DTE co 5% PEG- I K carbonate) was 
much lower compared to OS cells on other polymer substrates. however not stati sti cally 
significant. 
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Figure 4.11 Alkali ne Phosphatase acti vity of undifferentiated hMSCs (control) and OS 
cell s on polymer substrates. 
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Figure 4.12 Alkaline Phosphatase activi ty of OS cell s on polymer substrates at 
days I I and 14. 
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4.3.3 Calcium 
Calcium production is a marker for osteogenic differentiation . Therefore, in thi s 
experiment, undifferentiated hMSCs produced less calcium compared to as cells (Figure 
4.1 3). At day I I , calcium production of as cells on poly(DTE co 5% PEG-I K carbonate) 
was stati sti cally higher than poly(DTE carbonate) and poly(DTO carbonate) (Figure 
4.14). Calcium production was normalized to the average cell number obtained from the 
cell proliferation assay (Figure 4.15). At day II , calcium production normalized to cell 
number of as cell s on poly(DTE co 5% PEG-I K carbonate) was stati stically higher than 
poly(DTE carbonate) and poly(DTO carbonate). 
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Figure 4.13 Calcium production of undifferentiated hMSCs (control) and as cells on 
polymer substrates at days II and 14. Astelisks indicates a stati stically significant 
difference (p<O.05), between as cells on poly(DTE co 5% PEG-I K carbonate) to as 
cells on both poly( DTE carbonate) and poly(DTO carbonate). 
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Figure 4.14 Calcium production of OS cell s on polymer substrates. Asterisks indicates a 
stati stically significant difference (p<O.OS) between poly(DTE co 5% PEG-I K carbonate) 
to both poly(DTE carbonate) and poly(DTO carbonate). 
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Figure 4.15 Calcium production normalized to cell number of OS cell s on polymer 
substrates. Astelisks indicate statistical difference (p<O.OS), between poly(DTE co 5% 
PEG-I K carbonate) to both poly(DTE carbonate) and poly(DTO carbonate). 
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4.4 Effect of PEG on Osteogenic Differentiation
The data presented thus far demonstrate the anti-cell attachment effect on poly(DTE co
5% PEG-1K carbonate) as well as its effect on osteogenic differentiation markers. The
goal of this section was to determine the effect of the concentration of PEG on osteogenic
differentiation using poly(DTE co 3% PEG-1K carbonate) and poly(DTE co 5% PEG-1K
carbonate). Biochemical assay results were compared to poly(DTE carbonate) which was
conducted in a separate experiment in July 2005 (see section 4.3). Below are the results
of a 96 well plate experiment conducted in April 2006 using hMSC, Donor 2, passage 2.
Cells were seeded on poly(DTE co 3% PEG-1K carbonate) and poly(DTE co 5% PEG-
1K carbonate) to determine the effect of the concentration of PEG on osteogenic
differentiation. Data analysis was conducted using the Tukey-Kramer test between the
polymer substrates.
4.4.1 Cell Morphology
The modification of the molar fraction of PEG in the polycarbonate backbone, from 3%
to 5%, has a substantial effect on the cell morphology. The morphology of OS cells on
poly(DTE co 3% PEG-1K carbonate) by day 14 is a confluent monolayer, while the
morphology of OS cells on poly(DTE co 5% PEG-1K carbonate) by day 14 is exhibited
by the formation of cell aggregates.
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Figure 4.16 OS ce ll s at day 14 : (a) on poly(DTE co 3% PEG- I K carbonate), lOX (b) on 
poly(DTE co 5% PEG-I K carbonate), 20X. AtTOWS on (a) indicate cuboidal cell 
morphology. M Ows on (b) indicate cell aggregation 
4.4.2 Cell Proliferation 
The modifi cation of the molar fraction of PEG in the polycarbonate backbone, from 5% 
to 3%, has a positi ve effect on cell proliferation. OS cell s on poly(DTE co 3% PEG- I K 
carbonate) had a higher cell proliferation compared to OS cells on poly(DTE co 5% PEG-
I K carbonate) (Figure 4. 17). At day I I, OS cell number on poly(DTE co 3% PEG- I K 
carbonate) is stati sti cally higher than cell number on poly(DTE co 5% PEG- I K 
carbonate) (Figure 4.18). 
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Figure 4.17 Cell proliferation of undifferentiated hMSCs (control) and OS cell s on 
polymer substrates. 
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Figure 4.18 Cell proliferation of OS cells on polymer substrates . Asteri sks indicate 
stati stical difference (p<O.05), between poly(DTE co 5% PEG- I K carbonate) to both 
poly(DTE carbonate) and poly(DTE co 3% PEG- I K carbonate). 
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4.4.3 Alkaline Phosphatase 
The modifIcation of the molar fraction of PEG in the polycarbonate backbone, from 5% 
to 3%, has a positive effect in alkaline phosphatase activity at days II and 14. 
Undifferentiated hMSCs had lower alkaline phosphatase activity compared to OS cell s 
(Figure 4.19). By day II , there is negligible alkaline phosphatase activity in OS cells on 
poly(OTE co 5% PEG-I K carbonate). OS cells on (OTE co 3% PEG-I K carbonate) have 
a higher alkaline phosphatase activity compared to cells on poly(OTE co 5% PEG-I K 
carbonate) (Figure 4.20). 
Alkaline Phosphatase Activity 
5.00E-03 
4.00E-03 -1----------1---
::::-
~a; 
:§ -2 300E-03 
" .-
«.€ 
~ ~ 2.00E-03 
., a. 
el-
f!! 0 1.00E-03 
.,-
> 0 
« E 
c: ~ O.OOE+OO 
-1.00 E-03 
Day 4 Day 7 Day 11 
Date of Harvest 
• poly(DTE 
carbona te )-control 
I~-----'I 0 poly(DTE 
carbonate)-OS 
Day 14 
• poly(DTE co-3% 
PEG carbonate)-
control 
~ poly(DTE co-3% 
PEG carbonate)-OS 
-, I!!I poly(DTE co-5% 
PEG carbonate)-
control 
III poly(DTE co-5% 
.L PEG carbonate)-OS I 
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Figure 4_20 Alkaline phosphatase activity of as cell s 011 polymer substrates. 
4.4.4 Calcium 
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The modification of the molar fraction of PEG in the polycarbonate backbone, from 3% 
to 5%. has an increased effect on calcium production at day 14 (Figure 4.21 ). as cells on 
poly(DTE co 5% PEG-I K carbonate) had a statisticall y higher production of calcium per 
cell compared to as cells on poly(DTE co 3% PEG-l K carbonate) (Figure 4.22). 
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4.5 Biochemical Assays: 24 Well Plate Experiment
The following section is the quantitative representation of osteogenic differentiation in
terms of cell proliferation, alkaline phosphatase activity and calcium production on spin
coated disks in 24 well plates. Below are the results of an experiment conducted in
December 2005 using hMSC, Donor 2, passage 4. For each experiment, two graphs are
represented: one representing undifferentiated hMSCs and osteogenic differentiated
hMSCs (OS cells) (Figures 4.23. 4.25, 4.27) and the other representing only OS cells
(Figures 4.24, 4.26, 4.28, 4.29). Data analysis was conducted using the Tukey-Kramer
test between the polymer substrates.
4.5.1 Cell Proliferation
Cells were harvested at days 7 and 11 for DNA assay. At day 11, proliferation of OS cells
on poly(DTE co 5% PEG-1K carbonate) is statistically lower than both poly(DTE
carbonate) and poly(DTO carbonate). (Figure 4.23 and Figure 4.24)
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Figure 4.23 Cell proliferation of undifferentiated hMSCs (control) and OS cells on 
polymer substrates in a 14-day culture. Asteri sks indicates a statistically significant 
difference (p<O.05), between OS cells on poly(DTE co 5% PEG-I K carbonate) to OS 
cells on both poly(DTE carbonate) and poly(DTO carbonate). 
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Figure 4.24 Cell proliferation of OS cells on polymer substrates. Asterisks indicates a 
statisticall y significant difference (p<O.05) between poly(DTE co 5% PEG-I K carbonate) 
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4.5.2 Alkaline Phosphatase 
At day 7, alkaline phosphatase acti vity was negligib le. Undifferentiated hMSCs had 
lower a lkaline phosphatase acti vity compared to OS cells (Figure 4.25). Alka line 
phosphatase acti vity of OS cell s was not stat istically di fferent between substrates at day 
I I (Figure 4.26). 
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Figure 4.26 Alkaline Phosphatase activity of OS cells on polymer substrates. 
4.5.3 Calcium 
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Undifferentiated hMSCs produced much less calcium than osteogenic differentiated 
hMSCs (Figure 4.27). There was no stati stical difference in calcium production of OS 
cells between the polymer substrates (Figure 4.28). Calci um production was normali zed 
to the average cell number obtained from the cell proliferation assay. At day I I, calcium 
production normali zed to cell number of OS cells on poly(OTE co 5% PEG- I K 
carbonate) was stati stically higher than poly(OTE carbonate) and poly(OTO carbonate) 
(Figure 4.29). This effect was also observed in the 96 well experiment (Figure 4.15). 
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Figure 4_27 Calcium production of undifferentiated hMSCs (control) and OS on 
polymer substrates. 
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Figure 4.28 Calcium production of OS cell s on polymer substrates. 
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Figure 4.29 Calci um production normalized to cell number of OS cell s. Asterisks 
indicates a statisticall y significant difference (p<0.05), between poly(DTE co 5% PEG-
l K carbonate) to both poly(DTE carbonate) and poly(DTO carbonate). 
4.6 Cytoskeleton Staining 
Cytoskeleton staining is an indication of focal adhesion contacts onto the substrate. [n 
this experiment, there were differences in the focal adhesion contacts of undifferentiated 
hMSCs and osteogenic differentiated hMSCs (OS cells) on the various substrates. The 
actin cytoskeleton assembly of undifferentiated hMSCs has a parallel orientation (Figures 
4.30d, 4.31 d, 4.33d). However, the actin cytoskeleton assembly of OS cells has a mesh-
like orientation (Figures 4.30e, 4.31 e, 4.33e). As early as 5 hours, cell s have established 
adhesion contacts with the polymer substrates (Figure 4.30a, 4.3 la, and 4.33a). Cells on 
poly(DTE co 5% PEG-I K carbonate) did not establish focal adhesion contacts to the 
substrate (Figure 4.32). There was no actin filaments observed in cells seeded on 
58 
poly(DTE co 5% PEG carbonate). [mages shown here were taken at 5 hours, 4 days and 7 
days after initial seeding at a magnification of 20X. 
Cells on poly(DTE carbonate), 20X: (a) undifferentiated hMSCs on 
poly(DTE carbonate) 5 hours after seeding, (b) undifferentiated hMSCs on poly(DTE 
carbonate) at day 4, (c) OS cells on poly(DTE carbonate) at day 4, (d) undifferentiated 
hMSCs on poly(DTE carbonate) at day 7, (e) OS cells on poly(DTE carbonate) at day 7. 
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Figure 4.31 Cells on poly(DTO carbonate), 20X: (a) undifferentiated hMSCs on 
poly(DTO carbonate) 5 hours after seeding, (b) undifferentiated hMSCs on poly(DTO 
carbonate) at day 4. (c) OS cells on poly(DTO carbonate) at day 4, (d) undifferentiated 
hMSCs on poly(DTE carbonate) at day 7, (e) OS cells on poly(DTE carbonate) at day 7. 
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Figure 4.32 Cells on poly(DTE co 5% PEG· I K carbonate), 20X: (a) 
hMSCs on poly(DTE co 5% PEG- I K carbonate) at 5 hours after seeding, (b) 
undifferentiated hMSCs on poly(DTE co 5% PEG- I K carbonate) at day 4. (c) OS cells 
on poly(DTE co 5% PEG- I K carbonate) at day 4, (d) undifferentiated hMSCs on 
poly(DTE co 5% PEG- I K carbonate) at day 7, (e) OS cells on poly(DTE co 5% PEG-I K 
carbonate) at day 7. 
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Figure 4.33 Cells on ti ssue culture polystyrene (TCPS), 20X: (a) undifferentiated 
hMSCs on TCPS 5 hours after seeding, (b) undifferentiated hMSCs on TCPS at day 4, (c) 
OS cells on TCPS at day 4, (d) undifferentiated hMSCs on TC PS at day 7, (e) OS cells on 
TCPS at day 7. 
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4.7 QCM-D
The QCM-D data provides information about the thickness of the adsorbed protein layer.
The data for the change in frequency and dissipation was modeled to using 2 different
models: Voight and Sauerbrey. The Sauerbrey model is used to calculate the adsorbed
mass of thin, non-dissipative layers of protein, while the Voight model is used to
calculate the adsorbed mass of a thick dissipative layer of protein. In this particular
application, the Voight model is preferred.
With 10% FBS, there is no statistical difference in the thickness of the protein
layer between the substrates using the Voight model due to the high standard deviations
(Figure 4.34). However, the thickness of the adsorbed protein layer using the Sauerbrey
model, shows a statistical difference between poly(DTE co 5% PEG-1K carbonate) and
the other substrates (Figure 4.35). Although, the Sauerbrey model is not the preferred
model for this application, it can be generally concluded that the adsorbed layer of fetal
bovine serum on poly(DTE co 5% PEG-1K carbonate) is thinner compared to the other
substrates.
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Figure 4.34 Thickness of adsorbed layer of 10% FBS onto substrates USIng Voight 
model. 
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4.8 Cell Motility 
The goal of the cell motility experiment was to eval uate the relationship between cell 
substrate adhesion and cell-cell aggregation to motility by modifying the molar fraction 
of PEG in the polycarbonate backbone. The cell motility experiments were conducted in 
March 2006, using hMSCs, Donor 4, passage 2. The effect of the molar fract ion of PEG 
in the polycarbonate backbone, on motility is evident in this experiment. As osteogenic 
differentiation proceeds to day II , OS cells on poly(DTE co 3% PEG-I K carbonate) has 
an increased effect on random motility coefficient, velocity and persistence time 
compared to the other substrates (Figures 4.36-4.39). [t is interesting to note that the 
motility data collected at day I [ on poly(DTE co 3% PEG-I K carbonate) is the highest in 
the experiment. By day II , there is considerable minera li zation of the extracellular 
matrix. 
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CHAPTER 5
DISCUSSION AND FUTURE RESEARCH
The regenerative potential of mesenchymal stem cells (MSCs), along with the relative
ease in culturing these cells in vitro has made them an attractive candidate in many tissue
engineering applications such as bone graft substitutes. Properties of ideal substrates for
potential bone graft scaffolds are:
• Bone in-growth
• Porosity
• Mechanical integrity
• Bioresorbable
The bioresorbability and mechanical properties of tyrosine derived polycarbonates have
been well characterized, and are appropriate for orthopedic applications. The goal of this
study was to determine the extent of osteogenic differentiation of hMSCs on tyrosine
derived polycarbonates as a function of the alkyl ester pendent chain length and molar
percent of PEG in the polycarbonate backbone.
Tyrosine derived polycarbonates are a library of bioresorbable polymers that
possess the same backbone yet differ in the methyl groups of the alkyl ester pendent
chain. The polycarbonates that were chosen for this study: poly(DTE carbonate) and
poly(DTO carbonate) have two methyl groups and eight methyl groups respectively.
Tyrosine derived polycarbonate PEG copolymers have three modifiable parameters: the
alkyl ester pendent chain length, the molecular weight of PEG and the molar percent of
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PEG. In this study, two parameters remained fixed: the alkyl ester pendent chain (ethyl)
and the molecular weight of the PEG molecule (1000 kDa), while the molar
percent of PEG was adjusted between 3-5%. The modifications in the polymer chemistry
of polycarbonates, whether it is the addition of methyl groups in the alkyl ester pendent
chain or the incorporation of PEG in the backbone has a significant effect on the surface
wettability of the polymer, which is reflected in the contact angle measurements (Table
4.1). It was hypothesized that the surface wettability may have a negative effect on
osteogenic differentiation.
In this study, osteogenic differentiation was assessed with the quantitation of
osteoblast biomarkers: alkaline phosphatase, and calcium. Cell proliferation was the
determinant of cell attachment and surface biocompatibility. Osteogenic differentiation
was also determined by morphology and cytoskeletal organization.
In the preceding results of the biochemical assays on 96 well plates, it was shown
that there was no statistical difference in the osteogenic differentiation in terms of cell
proliferation, alkaline phosphatase activity, calcium and osteocalcin, between poly(DTE
carbonate) and poly(DTO carbonate). However, the presence of PEG in the backbone of
the polycarbonate had a profound impact on osteogenic differentiation. PEG has an anti-
attachment effect on cells, which is reflected in the decrease in the cell number from the
initial cell seeding density (Figure 4.10). There was no statistical difference between the
substrates in terms of alkaline phosphatase activity. However, the calcium production of
osteogenic differentiated cells normalized to cell number on poly(DTE co 5% PEG-1K
carbonate) is statistically greater compared to both poly(DTE carbonate) and poly(DTO
carbonate).
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There was no qualitative difference in the morphology of OS cells on poly(DTE
carbonate) and poly(DTO carbonate). On these substrates at late timepoints (7 and 11
days), OS cells formed a confluent single-cell monolayer. However, on poly(DTE co 5%
PEG-1K carbonate) at late timepoints, OS cells were characterized by sparse clusters of
cell aggregates (Figure 4.7e). In fact, aggregation was observed as early as 4 hours after
cell seeding (Figure 4.7a).
The cytoskeleton organization through actin-filament staining, indicates the focal
adhesion contacts between the cell and the substrates and is representative of the
integrin-ligand binding interactions. The ligand in this case, are the adsorbed proteins present in
the cell culture medium, onto the substrate. In this study, it was observed that cytoskeletal
organization of OS cells on the substrates: poly(DTE carbonate) and poly(DTO
carbonate) had a mesh-like orientation (Figure 4.30e and Figure 4.31e), in contrast the
cytoskeletal organization of hMSCs on these substrates had a parallel orientation (Figure
4.30d and Figure 4.31d). The cytoskeletal organization of cells grown on poly(DTE co
5% PEG-1K carbonate), (Figure 4.32) was not apparent, therefore concluding that these
cells did not form focal adhesion contacts to the substrates. Another interesting point is
that the morphology and cytoskeletal organization of cells grown on poly(DTE co 5%
PEG-1K carbonate) did not change from the mesenchymal stem cell to the osteogenic
differentiated cell. These observations suggest that aggregation, a cell-cell cohesive force
is much stronger than the cell-substrate adhesive force on polycarbonates containing 5%
PEG.
The biochemical profile, morphology and cytoskeletal organization of OS cells on
poly(DTE co 5% PEG-1K carbonate) is remarkably different compared to cells on the
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other polymer substrates. This could be due to an accelerated state of differentiation. The
differentiation of osteoblasts proceeds with proliferation, which decreases, as matrix
maturation and mineralization occurs[16]. The absence of proliferation and increased
mineralization of OS cells on poly(DTE co 5% PEG-1K carbonate) could be evidence of
a highly differentiated osteoblast. Further biochemical assays testing for the presence of
osteopontin must be done to prove this.
The phenomenon of cell aggregation versus cell-substrate adhesion and migration
on polycarbonates containing PEG was reported by Ryan et al, in which L929 mouse
fibroblasts were transfected with different cadherin clones and seeded on polycarbonates
containing various concentrations of PEG. It was shown that decreasing the molar
percent of PEG in polycarbonates increases the cell-substrate adhesion as well as
increasing the rate of emigration[34]. In this study, this phenomenon was observed on
cells seeded on poly(DTE co 3% PEG-1K carbonate) which were morphologically more
spread out than cells seeded on poly(DTE co 5% PEG-1K carbonate) (Figure 4.16), and
had a higher incidence of cell attachment indicated by the cell proliferation data. The
alkaline phosphatase activity of osteogenic differentiated cells on poly(DTE co 3% PEG-
1K carbonate) was higher compared to poly(DTE co 5% PEG-1K carbonate) (Figure
4.20). However, calcium released normalized to cell number is significantly higher on
cells on poly(DTE co 5% PEG-1K carbonate) (Figure 4.22).
Evidence from the data presented in this study as well as previous studies,
suggests that cell-substrate adhesion is a function of the molar percent of PEG into the
polycarbonate backbone. In this study, the relationship between cell-substrate adhesion
and motility of undifferentiated hMSCs and OS cells was evaluated. Cell-substrate
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adhesion was modified by increasing the molar percent of PEG in the backbone from 3%
to 5%. In previous reports, it was shown that there was a biphasic effect of PEG
concentration on motility, in that at concentrations of PEG (<3%), there was
unsubstantial cell motility, as the concentration of PEG increased to an intermediate
concentration (3-4%), motility increased, and then decreased at higher concentrations of
PEG (>8%). This effect was observed in the average velocity data at day 11, where OS
cells on poly(DTE carbonate) had an unsubstantial average velocity, while cells on
poly(DTE co 3% PEG-1K carbonate) had the highest average velocity and cells on
poly(DTE co 5% PEG-1K carbonate) had a lower average velocity (Figure 4.39). This
suggests that perhaps the proteins adsorbed to the surface of poly(DTE co 3% PEG-1K
carbonate) are of an optimum conformation, which may promote cell motility.
The conformation of the adsorbed protein layer was not determined in this study
but can be inferred from the thickness of the protein layer, which was determined using
the Q-CMD instrument. Serum albumin is a globular protein of dimensions of
approximately 8nm x 3.8nm [20]. It is hypothesized that substrates that do not contain
PEG have hydrophobic-hydrophobic interactions with proteins which cause the protein to
unfold and denature onto the surface. However, substrates containing PEG have
hydrophilic-hydrophobic interaction, and results in the stabilization of the protein's
globular structure. The average Voight thickness of 10% FBS on poly(DTE carbonate),
poly(DTO carbonate), poly(DTE co 3% PEG-1K carbonate), poly(DTE co 5% PEG-1K
carbonate), respectively is 11.46 ± 4.59 nm, 7.04 ± 3.99 nm, 6.64 ± 4.15 nm, and 5.23 ±
2.36 nm. An argument could be made that on poly(DTE carbonate), poly(DTO
carbonate) and poly(DTE co 3% PEG-1K carbonate) that there are multi-layers of
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denatured albumin present on the surface, being that the thickness values are greater than
3.8 nm and are almost multiples of 3.8 nm. However on poly(DTE co 5% PEG-1K
carbonate), it can be inferred that there is one layer of non-denatured protein. The protein
in the denatured state reveals bioactive sites that are recognized by integrins, in which the
binding to the protein leads to signal transduction by way of adhesion, differentiation and
motility. In order to successfully engraft MSCs onto a substrate, the interface between the
cell and substrate, mediated by protein adsorption must be determined.
The work presented in this study is very preliminary and there are many areas
where one can expand upon to gain a greater understanding of the cell substrate interface
and how it affects cell differentiation. Surface analysis of the thin film substrates in terms
of surface topography and residual composition must be analyzed, because it was evident
that there was a difference of osteogenic differentiation on spin coated disks and solvent
cast films. The surface topography of the spin coated disks was analyzed with SEM (refer
to Appendix C), and it was shown to be homogeneous. However this analysis was not
conducted on solvent cast films. Furthermore, the protein adsorption experiments must be
conducted with extracellular matrix proteins such as fibronectin, vitronectin, and type I
collagen which contain the integrin-binding sites: arginine-glycine-aspartate (RGD), that
are integral in cell adhesion and osteogenic differentiation. In fact, Salasznyk et al.
reported that hMSCs seeded on plates coated with vitronectin or type I collagen in the
absence of osteogenic induction medium, can cause differentiation along the osteogenic
lineage. Osteogenic differentiation may also be a function of the paracrine factors that
cells secrete and may be dependent on cell seeding density. Future studies using various
cell seeding densities must be considered. Another concern for future studies is donor
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variation. In thi s study, consistent osteogenic differentiation data was obtained with one 
donor "Donor 2". For analys is of different donor types, refer to Appendix B. For future 
studies. the effect of donor variation must be analyzed. Gene express ion, using RT-PCR 
technology will provide sensiti ve information about the expression of osteoblast 
biomarkers. 
The aim of thi s study was to screen tyrosi ne deri ved polycarbonates for potential 
substrates for bone graft scaffolds, which are three dimensional envi ronments. Therefore, 
understanding the in vivo nature of mature osteoblasts is imperati ve. In vivo, osteoblasts 
exhi bit a compact. columnar, apical structure that form a layer of cells at sites of ti ssue 
deposition (Figure 5. 1) 
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Figure 5.1 Histology of cancellous bone of cat. Bone is lined with osteoblasts and 
osteoc ytes [6]. 
This is in contrast to the spread-out morphology of OS cells in vitro on the two 
dimensional polymer substrates: poly( DTE carbonate), poly(DTO carbonate) and 
poly(DTE co 3% PEG-I K carbonate). OS cell s on poly(DTE co 5% PEG- l K carbonate) 
have a morphology which most resembles mature osteoblasts in vivo. FUllher 
experiments, on three dimensional scaffo lds should be implemented to determine whether 
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the morphology and biochemical profile of OS cells is differs from the two dimensional
environment.
In conclusion, osteogenic differentiation of human mesenchymal stem cells was
supported on tyrosine derived polycarbonates in the presence of osteoinductive medium
in vitro. OS cells on poly(DTE carbonate), poly(DTO carbonate) and poly(DTE co 3%
PEG-1K carbonate) are characterized by cell proliferation, the secretion of alkaline
phosphatase and calcium, focal adhesion contacts to the substrate and a cuboidal
morphology. Moreover, OS cells on poly(DTE co 3% PEG-1K carbonate) is
characterized by a relatively high average velocity and random motility coefficient,
which is ideal for bone remodeling. The differences in morphology, cytoskeletal
organization, cell proliferation and biochemical markers between poly(DTE co 5% PEG-
lK carbonate) and poly(DTE carbonate), poly(DTE carbonate) and poly(DTE co 3%
PEG-1K carbonate) may be an indication of a highly differentiated osteoblast and further
analysis must be made to prove this. These distinct cell responses induced by the polymer
substrate could be used in a variety of tissue engineering applications.
APPENDIX A 
BIOCHEMICAL ASSA YS INCLUDING TCPS SAMPLES 
Tissue Cul ture Polystyrene (TCPS) was used as an internal control for osteogenic 
differentiation. During the biochemical assays on polymer substrates, hMSCs were 
seeded onto 96 well TCPS plates (Becton Dickinson: BD 3072, Franklin Lakes, NJ) and 
24 well TC PS plates (Becton Dickinson: BD 35 3047, Franklin, NJ ). 
A.I Cell Proliferation on 96 Well Plates 
In thi s experiment cell proliferation over a 14 day culture was quantified using the DNA 
assay. 
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Figure A.I Cell proliferation of OS cells on polymer substrates. 
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A.3 Calcium Production on 96 Well Plates 
Calcium production. a marker for osteogenic differentiation was quantifi ed. 
3.00 E·03 
~ 2.50 E-03 
:2: 
~ 
E 2.00E-03 
'" '(3 
'" u 
1.50E-03 
Q) 
'" 
1.00E-03 
'" 
~ 
Q) 
> 
« 5.00E-04 
O.OO E+OO 
Calcium 
Day 11 Day 14 
Date of Harvest 
o p(DTE co 
5% PEG 
carbonate )-
OS 
o p(DTE 
carbonate )-
OS 
o p(DTO 
ca rbo na te)-
OS 
GJ TCPS-OS 
Figure A.3 Calcium production of OS cells on polymer substrates. 
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A.4 Cell Proliferation on 24 Well Plates 
In thi s experiment cell proli feration over a 14 day cul ture was quantified using the DNA 
assay. 
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A.S Alkaline Phosphatase Activity on 24 Well Plates 
Alkaline Phosphatase, a marker for osteogenic differentiation was quantified. 
1.00E-03 
8.00E-04 
>-= ,,"= Q.I 
6.00E-04 > " .- -
- r:: " .-
« E 
0..15. 4.00E-04 «z 
'" Q. Cl_ 
~ 0 
"'0 2.00E-04 
> E 
« r:: 
O.OO E+OO 
-2.00 E-04 
Alkaline Phosphatase Activity 
$ -
Day 7 Day 11 
Date of Harvest 
p(OTE co 
5%PEG 
carbonate)-OS 
o p(OTE 
carbonate)-OS 
o p(OTO 
carbonate)-OS 
IlHCPS-OS 
Figure A.6 Alkaline Phosphatase acti vity of as cells on polymer substrates. 
79 
A.6 Calcium on 24 Well Plates 
Calcium production, a marker for osteogenic differenti ation was quantifi ed. 
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Figure A.7 Calcium production o f as cell on polymer substrates. 
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A.7 Osteocalcin 
Osteocalcin is a marker for mature osteoblast differentiation[5J. The amount of 
osteocalcin present in the extracellular matlix of the samples was determined using the 
Intact Human Osteocalcin E[A kit (Biomedical Technologies, Stoughton, MA). [n this 
ELA kit, the provided standards and samples were quantified for osteocalcin by detecting 
the monoclonal antibody that is specific to it. A microplate coated with monoclonal 
antibody was treated with the standards and samples and osteocalcin antiserum for 2 and 
Y2 hours at 37°C. The plate was washed with phosphate-saline buffer 2-3 times before 
adding streptavidin-horseradish peroxidase for 30 minutes. The plate was washed again 
and a solution of hydrogen peroxide and TM B solution added to the plate, which was 
incubated fo r 10 minutes in the dark. The stop so lution was added to the wells of the plate 
and the resulting absorbance was read at 450 nm on the absorbance plate reader (Biotek). 
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A. 7.1 Osteocalcin Results 
At day I I, osteocalcin production on osteogenic di fferentiated hM SCs (OS) is 
stati sti ca ll y lower compared to the other substrates . Osteocalcin production was 
normali zed to average cell number. There was no stati stical difference between the 
substrates when normali zed to cell number. However, osteocalcin production normalized 
to cell number of the substrates is stati stically higher than osteocalcin production 
normali zed to cell number of ti ssue culture polystyrene . 
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Osteocalcin Production Normalized to Cell Number 
at Day 11 
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Figure A.IO OsteocaJcin normali zed to cell number, of OS cells on polymer substrates. 
APPENDIX B 
DONOR VARIABILITY 
Donor variation may have an effect on osteogenic differentiation, which was first 
evidenced by Phinney et al. In an experiment conducted in May 2005, donor variability 
was observed in cell proliferation and osteogenic differentiation assays on 96 well ti ssue 
culture polystyrene (TCPS) plates. [n thi s experiment, at day 14, it is evident that Donor 3 
has the highest calcium production and Alkaline Phosphatase activity, but the lowest cell 
number. Donors I and 2 have similar response at day 7 but not at day 14. [t is not known 
whether, the variability is inherent in the donors. 
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Figure B.2 Alkaline Phosphatase activ ity of OS cells of Donors 1-3 on TCPS. Asterisks 
at day 4, indicate statistical difference (p<O.05), between Donor 3 to both Donor I and 2. 
Asterisks at day 14, indicate stati stical difference (p<O.05) between Donor 2 to both 
Donor 2 and 3. 
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Figure 8 .3 Calcium production of OS cell s of Donors 1-3 on TCPS. Asterisks indicate 
statistical difference (p<O.05), between Donor 3 to both Donors 2 and 3. 
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Figure 8.4 Calci um normalized to cell number of OS cell s of Donors 1-3 on TCPS. 
Asterisks indicate stati stical difference (p<O.05), between Donor 3 to both Donor 2 and 3. 
APPENDIXC 
SEMIMAGING 
The integrity of the spin coated surface was observed with Scanning Electron Microscopy 
(SEM). The following SEM images are of spin coated di sks prepared in November 2005. 
The homogeneity of the surface indicated a smooth surface. SEM was not conducted on 
solvent cast films. 
Figure C.I SEM image of poly(DTE carbonate) at 2,020x. 
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Figure C.2 SEM image of poly(DTE co 5% PEG- I K carbonate) at 5,950X. 
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